Meeting the challenge of emerging pathogens: The role of the United States Air Force in global influenza surveillance

R. Joel Williams, Nancy J. Cox, Helen L. Regnery, Donald L. Noah, Ali S. Khan, Joy M. Miller, G. Bruce Copley, James S. Ice, James A. Wright

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Influenza virus is one of the most ubiquitous organisms on the planet, causing illness in much of the population each year. The dynamic nature of the influenza virus requires similarly dynamic surveillance and prevention initiatives. The efforts of national surveillance programs, overseen by the World Health Organization and administered by institutions such as the U.S. Centers for Disease Control and Prevention, the U.S. armed forces, and 60 to 70 collaborating laboratories, annually culminate in the development of effective influenza vaccines. The U.S. Air Force's contribution is via Project Gargle, through which bases in various locations worldwide conduct active surveillance and submit throat swab specimens for virus isolation and characterization; the results of these laboratory analyses help determine the composition of the following year's influenza vaccine. These collaborative efforts have resulted in an identical or close antigenic match between vaccine and epidemic strains in 8 of the last 9 influenza seasons.

Original languageEnglish (US)
Pages (from-to)82-86
Number of pages5
JournalMilitary medicine
Volume162
Issue number2
StatePublished - Feb 1 1997

Fingerprint

Influenza Vaccines
Orthomyxoviridae
Human Influenza
Air
Planets
Centers for Disease Control and Prevention (U.S.)
Pharynx
Vaccines
Viruses
Population

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health

Cite this

Williams, R. J., Cox, N. J., Regnery, H. L., Noah, D. L., Khan, A. S., Miller, J. M., ... Wright, J. A. (1997). Meeting the challenge of emerging pathogens: The role of the United States Air Force in global influenza surveillance. Military medicine, 162(2), 82-86.

Meeting the challenge of emerging pathogens : The role of the United States Air Force in global influenza surveillance. / Williams, R. Joel; Cox, Nancy J.; Regnery, Helen L.; Noah, Donald L.; Khan, Ali S.; Miller, Joy M.; Copley, G. Bruce; Ice, James S.; Wright, James A.

In: Military medicine, Vol. 162, No. 2, 01.02.1997, p. 82-86.

Research output: Contribution to journalArticle

Williams, RJ, Cox, NJ, Regnery, HL, Noah, DL, Khan, AS, Miller, JM, Copley, GB, Ice, JS & Wright, JA 1997, 'Meeting the challenge of emerging pathogens: The role of the United States Air Force in global influenza surveillance', Military medicine, vol. 162, no. 2, pp. 82-86.
Williams, R. Joel ; Cox, Nancy J. ; Regnery, Helen L. ; Noah, Donald L. ; Khan, Ali S. ; Miller, Joy M. ; Copley, G. Bruce ; Ice, James S. ; Wright, James A. / Meeting the challenge of emerging pathogens : The role of the United States Air Force in global influenza surveillance. In: Military medicine. 1997 ; Vol. 162, No. 2. pp. 82-86.
@article{117c7d29b754496781975872c1a49b6e,
title = "Meeting the challenge of emerging pathogens: The role of the United States Air Force in global influenza surveillance",
abstract = "Influenza virus is one of the most ubiquitous organisms on the planet, causing illness in much of the population each year. The dynamic nature of the influenza virus requires similarly dynamic surveillance and prevention initiatives. The efforts of national surveillance programs, overseen by the World Health Organization and administered by institutions such as the U.S. Centers for Disease Control and Prevention, the U.S. armed forces, and 60 to 70 collaborating laboratories, annually culminate in the development of effective influenza vaccines. The U.S. Air Force's contribution is via Project Gargle, through which bases in various locations worldwide conduct active surveillance and submit throat swab specimens for virus isolation and characterization; the results of these laboratory analyses help determine the composition of the following year's influenza vaccine. These collaborative efforts have resulted in an identical or close antigenic match between vaccine and epidemic strains in 8 of the last 9 influenza seasons.",
author = "Williams, {R. Joel} and Cox, {Nancy J.} and Regnery, {Helen L.} and Noah, {Donald L.} and Khan, {Ali S.} and Miller, {Joy M.} and Copley, {G. Bruce} and Ice, {James S.} and Wright, {James A.}",
year = "1997",
month = "2",
day = "1",
language = "English (US)",
volume = "162",
pages = "82--86",
journal = "Military Medicine",
issn = "0026-4075",
publisher = "Association of Military Surgeons of the US",
number = "2",

}

TY - JOUR

T1 - Meeting the challenge of emerging pathogens

T2 - The role of the United States Air Force in global influenza surveillance

AU - Williams, R. Joel

AU - Cox, Nancy J.

AU - Regnery, Helen L.

AU - Noah, Donald L.

AU - Khan, Ali S.

AU - Miller, Joy M.

AU - Copley, G. Bruce

AU - Ice, James S.

AU - Wright, James A.

PY - 1997/2/1

Y1 - 1997/2/1

N2 - Influenza virus is one of the most ubiquitous organisms on the planet, causing illness in much of the population each year. The dynamic nature of the influenza virus requires similarly dynamic surveillance and prevention initiatives. The efforts of national surveillance programs, overseen by the World Health Organization and administered by institutions such as the U.S. Centers for Disease Control and Prevention, the U.S. armed forces, and 60 to 70 collaborating laboratories, annually culminate in the development of effective influenza vaccines. The U.S. Air Force's contribution is via Project Gargle, through which bases in various locations worldwide conduct active surveillance and submit throat swab specimens for virus isolation and characterization; the results of these laboratory analyses help determine the composition of the following year's influenza vaccine. These collaborative efforts have resulted in an identical or close antigenic match between vaccine and epidemic strains in 8 of the last 9 influenza seasons.

AB - Influenza virus is one of the most ubiquitous organisms on the planet, causing illness in much of the population each year. The dynamic nature of the influenza virus requires similarly dynamic surveillance and prevention initiatives. The efforts of national surveillance programs, overseen by the World Health Organization and administered by institutions such as the U.S. Centers for Disease Control and Prevention, the U.S. armed forces, and 60 to 70 collaborating laboratories, annually culminate in the development of effective influenza vaccines. The U.S. Air Force's contribution is via Project Gargle, through which bases in various locations worldwide conduct active surveillance and submit throat swab specimens for virus isolation and characterization; the results of these laboratory analyses help determine the composition of the following year's influenza vaccine. These collaborative efforts have resulted in an identical or close antigenic match between vaccine and epidemic strains in 8 of the last 9 influenza seasons.

UR - http://www.scopus.com/inward/record.url?scp=0031036126&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031036126&partnerID=8YFLogxK

M3 - Article

C2 - 9038023

AN - SCOPUS:0031036126

VL - 162

SP - 82

EP - 86

JO - Military Medicine

JF - Military Medicine

SN - 0026-4075

IS - 2

ER -